These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20698580)

  • 1. Quantification of gemcitabine incorporation into human DNA by LC/MS/MS as a surrogate measure for target engagement.
    Wickremsinhe ER; Lutzke BS; Jones BR; Schultz GA; Freeman AB; Pratt SE; Bones AM; Ackermann BL
    Anal Chem; 2010 Aug; 82(15):6576-83. PubMed ID: 20698580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of gemcitabine prodrug, gemcitabine and its major metabolite 2', 2'-difluorodeoxyuridine in rat plasma by UFLC-MS/MS.
    Sun Y; Zhen L; Peng Y; Wang J; Fei F; Aa L; Jiang W; Pei X; Lu L; Liu J; Wang G; Hao K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():4-13. PubMed ID: 29558739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new, simple method for quantifying gemcitabine triphosphate in cancer cells using isocratic high-performance liquid chromatography.
    Nishi R; Yamauchi T; Ueda T
    Cancer Sci; 2006 Nov; 97(11):1274-8. PubMed ID: 17034368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry.
    Marangon E; Sala F; Caffo O; Galligioni E; D'Incalci M; Zucchetti M
    J Mass Spectrom; 2008 Feb; 43(2):216-23. PubMed ID: 17941128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry.
    Sottani C; Zucchetti M; Zaffaroni M; Bettinelli M; Minoia C
    Rapid Commun Mass Spectrom; 2004; 18(10):1017-23. PubMed ID: 15150823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines.
    Ruiz van Haperen VW; Veerman G; Vermorken JB; Peters GJ
    Biochem Pharmacol; 1993 Aug; 46(4):762-6. PubMed ID: 8363650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of gemcitabine and 2'-deoxycytidine in human plasma and tissue by APCI tandem mass spectrometry.
    Honeywell R; Laan AC; van Groeningen CJ; Strocchi E; Ruiter R; Giaccone G; Peters GJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):142-52. PubMed ID: 17056304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
    Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
    Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the anticancer agent gemcitabine and its deaminated metabolite at low concentrations in human plasma by liquid chromatography-mass spectrometry.
    Xu Y; Keith B; Grem JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):263-70. PubMed ID: 15018786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a template-located 2',2'-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3'-->5'exonuclease-) fragment.
    Schy WE; Hertel LW; Kroin JS; Bloom LB; Goodman MF; Richardson FC
    Cancer Res; 1993 Oct; 53(19):4582-7. PubMed ID: 8402631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ; Van Moorsel CJ; Lakerveld B; Smid K; Noordhuis P; Comijn EC; Weaver D; Willey JC; Voorn D; Van der Vijgh WJ; Pinedo HM
    Int J Oncol; 2006 Jan; 28(1):237-44. PubMed ID: 16328001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-clinical studies of gemcitabine--the mode of action and antitumor activities].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):393-400. PubMed ID: 10065109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography-tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy.
    Sun Y; Tang D; Chen H; Zhang F; Fan B; Zhang B; Fang S; Lu Q; Wei Y; Yin J; Yin X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():10-9. PubMed ID: 23396113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.
    Gandhi V; Mineishi S; Huang P; Yang Y; Chubb S; Chapman AJ; Nowak BJ; Hertel LW; Plunkett W
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):61-7. PubMed ID: 7481847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS method for quantitation of gemcitabine and its metabolite 2',2'-difluoro-2'-deoxyuridine in mouse plasma and brain tissue: Application to a preclinical pharmacokinetic study.
    Zhong B; Gibson EG; Davis A; Roussel MF; Stewart CF
    J Pharm Biomed Anal; 2021 May; 198():114025. PubMed ID: 33744463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic.
    Bookman MA
    Int J Gynecol Cancer; 2005; 15 Suppl 1():12-7. PubMed ID: 15839953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine.
    Vande Voorde J; Sabuncuoğlu S; Noppen S; Hofer A; Ranjbarian F; Fieuws S; Balzarini J; Liekens S
    J Biol Chem; 2014 May; 289(19):13054-65. PubMed ID: 24668817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of gemcitabine and its metabolite in human plasma by high-performance liquid chromatography.
    Yilmaz B; Kadioğlu YY; Aksoy Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):103-9. PubMed ID: 12798170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas.
    Gamblin TC; Egorin MJ; Zuhowski EG; Lagattuta TF; Herscher LL; Russo A; Libutti SK; Alexander HR; Dedrick RL; Bartlett DL
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):647-53. PubMed ID: 18040687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
    Vainchtein LD; Rosing H; Thijssen B; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2007; 21(14):2312-22. PubMed ID: 17577879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.